Analystreport

Horizon Pharma PLC (NASDAQ: HZNP) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report